Am J Transplant, Volume 17, Suppl 3 Archives - Page 78 of 181 - ATC Abstracts

2017 American Transplant Congress
Impact of Visceral and Subcutaneous Adipose Tissue on Post Donation Renal Function in Living Kidney Donors.
H. Lee,¹ S. Kang,¹ Y. Yoon,¹ K. Huh,² M. Kim,² S. Kim,² Y. Kim,² W. Han.¹
¹Urology, Yonsei University College of Medicine, Seoul, Korea; ²Transplantation Surgery, Yonsei University College of Medicine, Seoul, Korea
Introduction:It was reported that some variables were revealed remain renal function after live donor nephrectomy. This study was conducted to determine the influence of visceral…
2017 American Transplant Congress
The Effect of BMI on Renal Transplant Outcomes.
E. Giorgakis,¹ K. Reddy,¹ A. Singer,¹ H. Khamash,² R. Heilman.²
¹Department of Surgery, Mayo Clinic, Phoenix, AZ; ²Department of Medicine, Mayo Clinic, Phoenix, AZ
Purpose of the study was to explore the effect of BMI class on renal transplant outcomes.Method: Single center retrospective analysis of deceased and living donor…
2017 American Transplant Congress
Serum Alkaline Phosphatase Predicts Graft Failure and Mortality in Kidney Transplant Recipients.
Y. Kim,¹ S. Park,¹ S. Yang,² H. Lee,¹ Y. Kim,³ S.-K. Park,⁴ D. Han,³ I. Jung,⁵ J. Ha,⁶ C. Lim,⁷ Y. Kim,¹ J. Lee.⁷
¹Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; ²Seoul National University Biomedical Research Institute, Seoul, Republic of Korea; ³Division of Kidney Transplantation, Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁴Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁵Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; ⁶Surgery, Seoul National University Hospital, Seoul, Republic of Korea; ⁷Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea
Objective: Recent studies showed that high levels of serum alkaline phosphatase (ALP) are associated with all-cause or cardiovascular death among hemodialysis patients. However, there are…
2017 American Transplant Congress
Race, Admissions, and Renal Transplant Waitlisting.
R. Lynch, R. Zhang, R. Patzer, C. Larsen, A. Adams.
Surgery, Emory University, Atlanta, GA
Background: We have previously shown that increased hospitalization while listed for renal transplantation is associated with excess waitlist mortality, reduced odds of transplantation, and inferior…
2017 American Transplant Congress
Landscape of Multiple Donations from a Living Donor in the US.
A. Thomas,¹ A. Massie,¹ J. Garonzik-Wang,¹ K. Lentine,² M. Henderson,¹ D. Segev.¹
¹JHU, Baltimore; ²SLU, St. Louis
Guidelines for uncommon forms of living donation, such as multiple donations from the same person, are lacking. To inform future practice standards, we examined the…
2017 American Transplant Congress
Long-Term Outcome of Antibody-Mediated Rejection Due to Pre-Existing vs. De Novo DSA in Kidney Allograft Recipients.
O. Aubert,¹ C. Lefaucheur,¹ S. Higgins,¹ L. Hidalgo,² J. Duong Van Huyen,¹ D. Viglietti,¹ X. Jouven,¹ D. Glotz,¹ P. Halloran,² A. Loupy.¹
¹Paris Translational Research Center for Organ Transplantation, Paris, France; ²ATAGC, Edmonton, Canada
BackgroundAntibody-mediated rejection (ABMR) can occur in patients with pre-existing anti-HLA donor-specific antibodies (DSA) or in patients who develop de novo DSA. However, how these processes…
2017 American Transplant Congress
Prospective Randomized Trial for Predicting CMV Infection According to Baseline CMV-Specific T-Cell Immunity in Kidney Transplant Patients.
M. Jarque,² E. Melilli,¹ A. Gutierez,³ F. Moreso,⁴ L. Guirado,⁵ A. Manonelles,¹ J. Cruzado,^1,2 S. Luque,² E. Crespo,² N. Montero,¹ F. Diekman,⁶ J. Grinyó,^1,2 O. Bestard.¹
¹Nephrology Dep, Bellvitge Hospital, Barcelona, Spain; ²Nephrology Laboratory, IDIBELL, Barcelona, Spain; ³Kidney Transplant Unit, Hospital Miguel Servet, Zaragoza, Spain; ⁴Kidney Transplant Unit, Hospital Vall d'Hebrón, Barcelona, Spain; ⁵Kidney Transplant Unit, Fundació Puigvert, Barcelona, Spain; ⁶Kidney Transplant Unit, Hospital Clínic, Barcelona, Spain
Background: Despite the use of either anti-viral prophylaxis (PF) or preemptive (PE) therapy given based on donor/recipient IgG-serostatus, Cytomegalovirus (CMV) reactivation persists after kidney transplantation…
2017 American Transplant Congress
A Novel 3-Dimensional Culture System Enables In Vitro Study of Human Bone Marrow Plasma Cells.
J. Driscoll,¹ S. Tremblay,² S. Knechtle,³ E. Woodle.²
¹Medicine, Univ Cincinnati, Cincinnati, OH; ²Surgery, Univ Cincinnati, Cincinnati, OH; ³Transplant, Duke Univ, Durham, NC
Purpose: Historically, in vitro study of human plasma cells (PCs) has been greatly limited by their short survival (48-72 hrs). Therefore, systems that maintain viability…
2017 American Transplant Congress
Current Practice and Ethical Dimensions of Implementing APOL1 Testing into Living Donor Evaluation: A National Survey.
E. Gordon,¹ C. Wicklund,¹ R. Sharp,² J. Lee,¹ C. Johnson,¹ J. Friedewald.¹
¹Northwestern University, Chicago; ²Mayo Clinic, Rochester
BackgroundAfrican American (AA) live kidney donors (LKDs) have an even greater risk of kidney failure than European American live donors. Apolipoprotein 1 (APOL1) gene variants…
2017 American Transplant Congress
Disease Progression on Neoadjuvant Chemotherapy Is a Strong Predictor of Recurrence for Pediatric Hepatoblastoma.
M. Kueht,¹ S. Commander,¹ T.-A. Ha,¹ A. Rana,^1,2 Y. Shi,¹ S. Vasudevan,^1,2 J. Goss.^1,2
¹Surgery, Baylor College of Medicine, Houston; ²Surgery, Texas Children's Hospital, Houston
Purpose. In addition to peri-operative chemotherapy, proper triage between orthotopic liver transplantation (OLT) and partial hepatectomy (PH) is critical to limiting disease recurrence in pediatric…